Slides
Page 1
SECURING HARVESTS, NURTURING FUTURES. Investor Presentation May 2025
Page 2
2 SAFE HARBOR This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment thereof. In particular, this presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to otherwise notify the recipient if the information, opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate. Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.” You can generally identify forward looking statements by terminology such as “aim” , “anticipate” , “believe” , “continue” , “could” , “estimate” , “expect” , “intend” , “may” , “objective” , “goal” , “plan” , “potential” , “project” , “pursue” , “shall” , “should” , “will” , “would” , or other words or phrases of similar import. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or other projections. Important factors that could cause actual results, performance or achievements to differ materially include, among others: (a) our ability to successfully implement our strategy, (b) our growth and expansion plans, (c) changes in regulatory norms applicable to the Company, (d) technological changes, (e) investment income, (f) cash flow projections, and (g) other risks. This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such change or changes.
Page 3
About Sharda Cropchem Limited
Page 4
“We are a fast-growing global agrochemicals company with a peer position in the generic crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North America and Latin America. It equips us with the ability to operate in a diversified range of formulations and generic active ingredients space globally”
Page 5
AGROCHEMICAL FOCUSED COMPANY Sharda Cropchem is an Intellectual Property (IP) driven company engaged in marketing and distribution of wide range of formulations and generic active ingredients Company’s apt domain knowledge and experience gives substantial competitive advantage for expanding business in existing markets and new geographies Asset Light Business Model : Efficiently channelizing time and resources for strengthening core competency of identifying generic molecules and registration opportunities which offer scalable growth with limited capital requirements Large Pipeline of Registrations* : Procured 2,964 registrations. Additionally, it has filed 1,014 applications for registrations globally pending at different stages Diversified Sourcing Arrangements : Enduring relationship with multiple manufacturers and formulators enables to source and supply formulations or generic active ingredients at competitive prices Consistently Increasing Global Presence : With diversified range of product portfolio, Company has grown by expanding business operations in 80+ countries, across Europe, NAFTA, Latin America and ROW Widespread Distribution Network : Presence in the entire agrochemical value chain with 525 third party distributors and 500+ sales force serving the Company’s esteemed clientele in 80+ countries *As on 31st March 2025
Page 6
6 ASSET LIGHT BUSINESS MODEL Overall Agrochemical Value Chain Sharda’s Operating Area Basic & Applied Research Identification Registration Active Ingredient Manufacturing Formulation & Packaging Marketing & Distribution √ √ √ √ Focus on identification of generic molecules, preparing dossiers, seeking registrations, marketing & distributing formulations through third-party distributors and/or own sales force Manufacturing of AIs and formulations is outsourced Acts as a key differentiator from an innovator company, allowing the Company to save its capital, time and resources on R&D Highly flexible operating model resulting in : • Overall cost competitiveness • Efficient management of fluctuating market demand across various geographies • Offering wide range of formulations and AIs
Page 7
7 INCREASING GLOBAL PRESENCE WITH A WIDESPREAD DISTRIBUTION In addition to newer markets, the wide global presence has allowed us to find new, specialised sales and local marketing talent. Successfully adopted a factory-to- farmer approach to become a one- stop solution provider to our global customers Strengthening and widening the sales force in Europe, USA, Canada, Mexico, Colombia, South Africa, India, and rest of the world, in addition to third party distributors with a goal to enhance its presence in the agrochemical value chain It enables the Company to penetrate its formulations and generic active ingredients in various countries backed by the third-party distributors and presence of its own sales force Company has gained a great deal from globalization, including new customers and diverse geocentric revenue streams. Over the years, we have mastered flexibility and adopted innovative ways to grow our business overseas Presence 80+ countries across Europe, NAFTA, LATAM & RoW Global Resource Deployment 500+ Distributors 525+ CAPEX incurred in FY25* Rs. 420 Cr. * Plus related revenue expenditure on registrations Over the years, the Company has built a strong brand franchise within our global markets; we are benefiting through the economies of scale in our portfolio and leveraging value of our supply chain to deliver value to our customers across geographies
Page 8
The Sharda Advantage Global Reach Wide Product Range Healthy Relationships with Suppliers Quality with Affordability Faster Sales Service One Stop Solution Provider for Crop Care Products
Page 9
9 WAY FORWARD Forward Integration - Build Sales Force ✓ Leverage market presence and execution capabilities ✓ Adopt the factory to farmer approach and be a one stop solution provider ✓ Strategy on ground in different regions of NAFTA, Europe, LATAM and other key markets in ROW 1 Expand & Strengthen Distribution Presence ✓ Expand geographical reach using existing library of dossiers ✓ Two-fold strategy of further penetrating existing markets and entering new markets 2 Continual Investment in Product Registrations ✓ Continue to identify generic molecules going off patent ✓ Investing in preparing dossiers and seeking registrations in own name 3 Focus on Operational Efficiencies ✓ Accelerated focus on revenue generating investments ✓ Margin improvements ✓ Better cost management and eliminate NVAs 4
Page 10
10 INDUSTRY OUTLOOK & GROWTH DRIVERS INDUSTRY DRIVERS A Growing Population: Global population is set to increase by 1.2 billion by 2030 and 2 billion by 2050, while the middle class will more than double to 4.9 billion by 2030 A growing middle class fuels demand for increased food and protein production, which in turn drives demand for grain to support growth Fewer arable acres per capita means that products need to continue to maximise farmer yields; arable land is expected to decrease from half an acre per person today to less than one-third of an acre per person by 2050 Global crop protection (In Billion USD) – CAGR of 4.3% 92.2 134.7 FY23 FY32e +4.3% Source : Annual Report (FY24)
Page 11
Experienced Management Mr. Ramprakash V. Bubna Chairman & Managing Director ✓ Holds a Bachelor’s Degree of Technology in Chemical Engineering from IIT, Bombay ✓ He has over 56 years of experience in chemicals, agrochemicals and related businesses ✓ He is responsible for the Company’s overall business operations and strategy Mr. Ashish Bubna Whole Time Director ✓ Holds a Bachelor’s Degree in Commerce from the University of Mumbai ✓ Over 33 years of experience in marketing of chemicals, agrochemicals and related businesses. ✓ Instrumental in strategizing early investment in product registrations and building the library of product dossiers. ✓ Responsible for marketing, procurement, registrations and logistics functions of the agrochemical business. Mr. Manish Bubna Whole Time Director ✓ Holds a Bachelor’s Degree in Chemical Engineering from the Department of Chemical Technology, Bombay University. ✓ Over 31 years of experience in chemicals, agrochemicals and related businesses ✓ Spearheaded the Company’s foray into the conveyor belt and general chemicals business ✓ Also oversees the information technology, logistics and documentation functions of the Company
Page 12
Q4 FY25 Financial Highlights
Page 13
13 Q4 FY25: SEGMENT WISE HIGHLIGHTS Q4 FY24 Q4 FY25 1,215 1,691 +39% Agrochemical Segment Q4 FY24 Q4 FY25 97 138 +42% Non-Agrochemical Segment Q4 FY24 Q4 FY25 1,312 1,829 +39% TOTAL REVENUES 93% 92% 7% 8% 100% 100%% of Revenue Cr. On Consolidated Basis
Page 14
14 Q4 FY25: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment) Herbicides 45% 50% % of Revenue Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 18% 17% 38% 33% 100% 100% Cr. Q4 FY24 Q4 FY25 542 850 +57% Q4 FY24 Q4 FY25 216 284 +31% Q4 FY24 Q4 FY25 458 557 +22% Q4 FY24 Q4 FY25 1,215 1,691 +39%
Page 15
15 Q4 FY25: REGION WISE BREAKUP (Agrochemical Segment) Q4 FY24 Q4 FY25 1,215 1,691 +39% TOTAL REVENUES (Agrochemical Segment) % of Revenue Europe 64% 66% LATAM Region 3% 2% NAFTA Region 28% 29% RoW 5% 3% On Consolidated Basis Q4 FY24 Q4 FY25 782 1,115 +43% Q4 FY24 Q4 FY25 340 493 +45% Q4 FY24 Q4 FY25 33 39 +19% Q4 FY24 Q4 FY25 60 44 -26% Cr.
Page 16
16 Q4 FY25: REGION WISE BREAKUP (Non - Agrochemical Segment) Q4 FY24 Q4 FY25 97 138 +42% TOTAL REVENUES (Non - Agrochemical Segment) % of Revenue Europe 17% 14% LATAM Region 5% 8% NAFTA Region 62% 68% RoW 16% 9% On Consolidated Basis Q4 FY24 Q4 FY25 16 20 +19% Q4 FY24 Q4 FY25 60 94 +57% Q4 FY24 Q4 FY25 5 11 +142% Q4 FY24 Q4 FY25 16 13 -19% Cr.
Page 17
17 Q4 FY25 : FINANCIAL HIGHLIGHTS Revenues & GP Margin EBITDA Profit After Tax 1,312 1,829 Q4 FY24 Q4 FY25 +39% 34.6% 29.8% 303 352 Q4 FY24 Q4 FY25 +16.2% 143 204 Q4 FY24 Q4 FY25 +41.9% Cr. On Consolidated Basis ✓ Revenue in Q4 FY25 increased by 39% primarily driven by higher volumes. We saw volume growth across all major regions i.e. Europe, NAFTA & LATAM ✓ Agrochemical volumes grew by 48.4% in Q4 FY25 ✓ Non-Agrochemical volumes grew by 115.6% in Q4 FY25 ✓ Gross Margins are at 29.8%. These margins are expected to improve further in FY26 with prices expected to increase ✓ EBITDA for the quarter grew by 16% to Rs. 352 crores as compared to Rs. 303 crores in Q4 FY24 with EBITDA Margins at 19.2% ✓ PAT for the quarter grew by 42% to Rs. 204 crores as compared to Rs. 143 crores in Q4 FY24
Page 18
FY25 Financial Highlights
Page 19
19 FY25: SEGMENT WISE HIGHLIGHTS FY24 FY25 2,639 3,773 +43% Agrochemical Segment FY24 FY25 524 547 +4% Non-Agrochemical Segment FY24 FY25 3,163 4,320 +37% TOTAL REVENUES 83% 87% 17% 13% 100% 100%% of Revenue Cr. On Consolidated Basis
Page 20
20 FY25: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment) Herbicides 50% 53% % of Revenue Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 21% 19% 29% 28% 100% 100% Cr. FY24 FY25 1,313 1,995 +52% FY24 FY25 562 721 +28% FY24 FY25 765 1,058 +38% FY24 FY25 2,639 3,773 +43%
Page 21
21 FY25: REGION WISE BREAKUP (Agrochemical Segment) FY24 FY25 2,639 3,773 +43% TOTAL REVENUES (Agrochemical Segment) % of Revenue Europe 57% 58% LATAM Region 6% 5% NAFTA Region 31% 33% RoW 6% 5% On Consolidated Basis FY24 FY25 1,501 2,177 +45% FY24 FY25 822 1,227 +49% FY24 FY25 155 191 +23% FY24 FY25 161 178 +11% Cr.
Page 22
22 FY25: REGION WISE BREAKUP (Non - Agrochemical Segment) FY24 FY25 524 547 +4% TOTAL REVENUES (Non - Agrochemical Segment) % of Revenue Europe 16% 14% LATAM Region 6% 9% NAFTA Region 58% 67% RoW 20% 10% On Consolidated Basis FY24 FY25 85 77 -9% FY24 FY25 305 367 +20% FY24 FY25 31 47 +55% FY24 FY25 103 55 -47% Cr.
Page 23
23 FY25 : FINANCIAL HIGHLIGHTS Revenues & GP Margin EBITDA Profit After Tax 3,163 4,320 FY24 FY25 +37% 25.9% 29.9% 318 682 FY24 FY25 +114.3% 32 304 FY24 FY25 +854.1% Cr. On Consolidated Basis ✓ Revenue in FY25 increased by 37% primarily driven by higher volumes and a gradual price increase. We saw volume growth across all major regions i.e. Europe, NAFTA & LATAM ✓ Agrochemical volumes grew by 43.9% in FY25 ✓ Non - Agrochemical volumes grew by 9.0% in FY25 ✓ Gross Margins have increased by 400 bps to 29.9% and it is expected to further improve in FY26 with prices expected to increase ✓ EBITDA for the year more than doubled to Rs. 682 crores as compared to Rs. 318 crores in FY24. EBITDA Margins stood at 15.8% ✓ PAT for the year stood at Rs. 304 crores as compared to Rs. 32 crores in FY24
Page 24
24 STRONG BALANCE SHEET 158 days 123 83 192 146157 111 Mar-24 Mar-25 Inventory Days Recievable Days Creditor Days Working Capital (in Days) 118 days Total Equity Cash, Bank & Liquid Investments On Consolidated Basis Rs. 2,501 crores Rs. 2,237 crores as on Mar’24 Rs. 558 crores Rs. 375 crores as on Mar’24 Reduced Working Capital by 40 days RoCE* 16.0% RoE* 12.8% * ROCE = EBIT / Average Capital Employed ; RoE = PAT / Average Equity
Page 25
Annexure
Page 26
26 Q4 & FY25 FINANCIAL HIGHLIGHTS * EBITDA is excluding IA & IAUD write-off (Rs. 59.2 cr. in Q4 FY25; Rs. 28.9 cr. in Q4 FY24; Rs.68.1 cr. In FY25; Rs.34.9 cr. in FY24) Particulars Q4 FY25 Q4 FY24 Y-o-Y FY25 FY24 Y-o-Y Revenue from Operations 1,828.5 1,312.1 39% 4,319.9 3,163.0 37% COGS 1,284.5 858.3 3,028.1 2,342.4 Gross Profit 544.0 453.8 20% 1,291.8 820.6 57% Gross Margin % 29.8% 34.6% 29.9% 25.9% Employee Expenses 18.2 14.7 52.0 42.4 Other Expenses 233.2 165.3 626.3 495.0 EBITDA* 351.8 302.7 16% 681.6 318.1 114% EBITDA Margin % 19.2% 23.1% 15.8% 10.1% Forex (Gain)/Loss -10.5 19.0 17.9 0.4 Depreciation 71.9 54.3 274.7 267.1 Other Income 25.2 -2.0 59.5 59.8 EBIT 256.5 198.6 29% 380.4 75.5 404% EBIT Margin % 14.0% 15.1% 8.8% 2.4% Finance Cost 0.4 0.2 2.1 3.6 PBT 256.1 198.4 29% 378.3 71.9 426% Tax Expense 52.5 54.9 73.9 40.0 PAT 203.6 143.5 42% 304.4 31.9 854% PAT Margin % 11.1% 10.9% 7.0% 1.0% Earnings Per Share (EPS) In Rs. 22.57 15.90 33.74 3.53 On Consolidated Basis Cr.
Page 27
27 BALANCE SHEET EQUITY & LIABILITIES Mar-25 Mar-24 Equity Equity share capital 90.2 90.2 Other equity 2,410.3 2,146.9 Equity attributable to equity holders of the Company 2,500.6 2,237.1 Non-controlling interests 0.4 0.4 Total Equity 2,501.0 2,237.5 Non-current liabilities Financial liabilities Lease liabilities 0.0 7.8 Other financial liabilities 63.0 58.4 Provisions 1.3 1.3 Deferred tax liabilities (net) 173.8 152.8 Total non-current liabilities 238.1 220.3 Current liabilities Financial liabilities Borrowings 0.0 3.4 Lease liabilities 7.8 7.2 Trade payables total outstanding dues of micro enterprises and small enterprises 5.1 6.9 other than micro enterprises and small enterprises 1,305.1 914.2 Other financial liabilities 501.3 502.5 Other current liabilities 104.7 69.0 Provisions 57.6 76.0 Income Tax Provisions 4.2 1.5 Total current liabilities 1,985.7 1,580.5 Total Equity & Liabilities 4,724.9 4,038.3 ASSETS Mar-25 Mar-24 Non-current assets Property, plant and equipment 3.0 3.8 Right to use assets 7.2 14.4 Goodwill 0.0 0.0 Intangible assets 740.2 690.0 Intangible assets under development 291.4 282.9 Financial assets Other Financial Assets 5.4 5.3 Deferred Tax Assets 11.6 10.3 Income tax assets (net) 63.4 72.1 Other non-current assets 16.4 21.7 Total non-current assets 1,138.5 1,100.4 Current assets Inventories 971.9 991.6 Financial assets Investments 294.3 158.9 Trade receivables 1,955.4 1,498.0 Cash and cash equivalents 127.2 87.3 Bank balance other than cash and cash equivalents 93.1 0.6 Loans 0.0 0.0 Other financial assets 47.5 128.1 Other current assets 96.8 73.4 Total current assets 3,586.4 2,937.9 Total Assets 4,724.9 4,038.3 On Consolidated Basis Cr.
Page 28
28 CASH FLOW STATEMENT Particulars FY25 FY24 Profit Before Tax 378.3 71.9 Adjustments 286.8 272.8 Operating profit before working capital changes 665.1 344.6 Changes in working capital -30.5 47.0 Cash generated from operations 634.6 391.7 Direct taxes paid (net of refund) -31.0 -50.4 Net Cash from Operating Activities 603.7 341.3 Net Cash from Investing Activities -510.1 -393.5 Net Cash from Financing Activities -67.9 -36.9 Exchange difference arising on conversion (debited) / credited to foreign currency translation reserve 14.3 0.6 Net Change in cash and cash equivalents 40.0 -88.5 Opening Cash Balance 87.3 176.4 Effect of exchange rate changes on cash & cash equivalents held in foreign currencies -0.1 -0.5 Closing Cash Balance 127.2 87.3 On Consolidated Basis Cr.
Page 29
29 KEY FINANCIAL PERFORMANCE INDICES Revenue EBITDA & EBITDA Margin* Profit After Tax & PAT Margin 2,396 3,580 4,045 3,163 4,320 FY21 FY22 FY23 FY24 FY25 455 729 713 318 682 FY21 FY22 FY23 FY24 FY25 229 349 342 32 304 FY21 FY22 FY23 FY24 FY25 RoCE RoE Cash, Bank & Liquid Investments^ FY21 FY22 FY23 FY24 FY25 20.2% 25.7% 20.8% 3.4% 16.0% 276 262 325 375 558 FY21 FY22 FY23 FY24 FY25FY21 FY22 FY23 FY24 FY25 15.2% 19.8% 16.5% 1.4% 12.8% ^ Total Cash & Cash Equivalents (Includes FDs of Rs. 128 crores clubbed in Non Current Other Financial Assets) 19.0% 20.4% 17.6% 10.1% 9.6% 9.8% 8.5% 1.0% * EBITDA is excluding IA & IAUD write-off On Consolidated Basis Cr. 15.8% 7.0%
Page 30
30 HISTORICAL PROFIT & LOSS Particulars FY25 FY24 FY23 FY22 FY21 Revenue from Operations 4,319.9 3,163.0 4,045.2 3,579.8 2,395.6 COGS 3,028.1 2,342.4 2,860.8 2,499.8 1,636.0 Gross Profit 1,291.8 820.6 1,184.4 1,080.0 759.7 Gross Margin % 29.9% 25.9% 29.3% 30.2% 31.7% Employee Expenses 52.0 42.4 44.8 44.2 37.3 Other Expenses 626.3 494.9 438.9 336.4 305.5 EBITDA* 681.6 318.1 712.6 728.6 455.2 EBITDA Margin % 15.8% 10.1% 17.6% 20.4% 19.0% Forex (Gain)/Loss 17.9 0.4 57.6 16.5 -19.9 Depreciation 274.7 267.1 248.1 245.3 170.4 Other Income 59.5 59.8 40.3 28.9 45.9 EBIT 380.4 75.5 435.3 466.5 312.2 EBIT Margin % 8.8% 2.4% 10.8% 13.0% 13.0% Finance Cost 2.1 3.6 4.5 2.2 2.8 PBT 378.3 71.9 430.7 464.2 309.5 Tax Expense 73.9 40.0 88.8 115.0 80.2 PAT 304.4 31.9 342.0 349.3 229.2 PAT Margin % 7.0% 1.0% 8.5% 9.8% 9.6% Earnings Per Share (EPS) In Rs. 33.74 3.53 37.90 38.71 25.40 Cr. * EBITDA is excluding IA & IAUD write-off On Consolidated Basis
Page 31
31 BALANCE SHEET – EQUITY & LIABILITIES Equities & Liabilities FY25 FY24 FY23 FY22 FY21 Shareholder's Funds Equity and Share Capital 90.2 90.2 90.2 90.2 90.2 Other Equity 2,410.4 2,146.9 2,141.8 1,822.2 1,524.1 Non-controlling Interest 0.4 0.4 0.4 0.3 0.3 Total Equity 2,501.0 2,237.5 2,232.4 1,912.8 1,614.6 Non-Current Liabilities Borrowings - - - - - Trade Payables - - - 2.4 2.4 Lease Liabilities - 7.8 - 3.5 8.4 Other Financial Liabilities 63.0 58.4 1.7 1.6 3.2 Provisions 1.3 1.4 2.7 2.3 3.0 Deferred Tax Liabilities (net) 173.8 152.8 143.4 128.9 92.9 Total Non-Current Liabilities 238.1 220.3 147.9 138.6 109.9 Current Liabilities Borrowings - 3.4 3.0 38.0 67.8 Lease Liabilities 7.8 7.2 0.0 5.1 4.5 Trade Payables 1,310.2 921.2 1,377.6 1,177.6 806.8 Other Financial Liabilities 501.3 502.5 431.4 324.8 149.1 Other Current Liabilities 104.7 69.0 78.1 55.4 58.0 Current Tax Liabilities 4.2 1.5 61.4 4.2 3.2 Provisions 57.6 76.0 19.1 86.7 50.0 Total Current Liabilities 1,985.7 1,580.5 1,970.6 1,691.8 1,139.4 Total Equity & Liabilities 4,724.9 4,038.3 4,350.8 3,743.1 2,863.9 On Consolidated Basis Cr.
Page 32
32 BALANCE SHEET – ASSETS ASSETS FY25 FY24 FY23 FY22 FY21 Assets Non-Current Assets Property, Plant and Equipment 3.0 3.8 5.0 14.4 20.9 Right to Use Assets 7.2 14.4 0.0 - - Goodwill 0.0 0.0 0.0 0.0 0.4 Other Intangible assets 740.2 690.0 663.0 577.4 523.1 Intangible assets under development 291.4 282.9 203.9 212.2 131.0 Deferred Tax Assets (net) 11.6 10.3 7.9 4.9 6.0 Non-Current Tax Assets 63.4 72.1 72.3 71.6 73.6 Other financial assets 5.4 5.3 120.7 11.2 9.4 Other Non Current Assets 16.4 21.7 19.9 0.0 0.0 Total Non-Current Assets 1,138.5 1,100.4 1,092.7 891.7 764.5 Current Assets Inventories 971.9 991.6 1,134.3 892.8 525.5 Investments 294.3 158.9 31.9 134.4 83.0 Trade Receivables 1,955.4 1,498.0 1,833.3 1,540.0 1,162.6 Cash & Cash equivalents 127.2 87.3 176.4 56.7 85.6 Other Bank balances 93.1 0.6 0.2 109.3 175.0 Loans 0.0 0.0 0.0 0.5 - Other Financial Assets 47.5 128.1 5.5 48.9 28.1 Other Current Assets 96.8 73.4 76.5 68.9 39.6 Total Current Assets 3,586.4 2,937.9 3,258.2 2,851.5 2,099.3 Total Assets 4,724.9 4,038.3 4,350.8 3,743.1 2,863.9 On Consolidated Basis Cr.
Page 33
33 CSR ACTIVITIES CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects Promoting Education Animal Welfare Medical Aid & Relief
Page 34
Company: Sharda Cropchem Limited CIN: L51909MH2004PLC145007 THANK YOU Mr. Shailesh Mehendale – CFO cfo@shardaintl.com / finance@shardaintl.com Tel: +91 22 6678 2800 Mr. Deven Dhruva deven.dhruva@sgapl.net Tel: +91 98333 73300 Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd. CIN: U74140MH2010PTC204285 SECURING HARVESTS, NURTURING FUTURES.